FDA product code GXH: Device, Surgical, Cryogenic

GXH is the FDA product code for device, surgical, cryogenic. It is a Class II device, regulated under 21 CFR 882.4250 and reviewed by the Neurology panel. FDA has cleared 23 510(k) submissions under GXH, 5 in the last five years, from 8 different applicants. The average 510(k) review took 93 days (median 60); 44 days on average over the last three years. FDA has posted 2 recalls for GXH devices.

Classification

FieldValue
Device nameDevice, Surgical, Cryogenic
Device classClass II
Regulation21 CFR 882.4250
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for GXH

YearClearancesAvg. review days
20171262
2018353
20201281
20211130
2022174
2023129
2024229
2025159

Compare with all 510(k) review times · Search every GXH clearance

Top GXH applicants

ApplicantClearancesLatest
Myoscience, Inc.82018-02-28
AtriCure, Inc.72025-04-10
Pacira Biosciences, Inc.22024-12-26
Spembly Medical , Ltd.21983-08-12
Pacira Pharmaceuticals, Inc.12021-09-10

3 more applicants have GXH clearances. See the full list in Caduvo.

Most recent GXH clearances

510(k)ApplicantDeviceDecision dateReview days
K250371AtriCure, Inc.cryoICE cryoXT cryoablation probe (cryoXT)2025-04-1059
K243677Pacira Biosciences, Inc.iovera° System2024-12-2629
K243157AtriCure, Inc.AtriCure cryoICE BOX (ACM)2024-10-2929
K233170AtriCure, Inc.cryoICE cryoSPHERE+ Cryoablation Probe (CRYOSP); cryoICE cryoSPHERE+ Cryoablation Probe (CRYOSP-L); cryoICE cryoSPHERE MAX Cryoablation Probe (CRYOSMAX); cryoICE cryoSPHERE MAX Cryoablation Probe (CRYOSMAX-L)2023-10-2629
K220656Pacira Biosciences, Inc.iovera System2022-05-2074

Recalls for GXH devices

2 product recalls in 2 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2015-07-01.

Frequently asked questions

What is FDA product code GXH?

GXH is the FDA product code for device, surgical, cryogenic. It is a Class II device, regulated under 21 CFR 882.4250 and reviewed by the Neurology panel.

What device class is GXH?

Class II, regulation 21 CFR 882.4250. Typical premarket route: 510(k).

How long does a 510(k) take for product code GXH?

Across 23 cleared submissions the average was 93 days from receipt to decision (median 60).

Which companies have the most GXH clearances?

Myoscience, Inc. (8); AtriCure, Inc. (7); Pacira Biosciences, Inc. (2); Spembly Medical , Ltd. (2); Pacira Pharmaceuticals, Inc. (1).

Have GXH devices been recalled?

Yes: 2 product recalls across 2 recall events; the most recent began 2015-07-01.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times